Dr. Jeffrey Hoffman
Dr. Hoffman completed his medical training and obtained a Ph.D. in experimental pathology at the University of Washington. Dr. Hoffman was an active basic science researcher and published extensively in basic research. Dr. Hoffman remains active in clinical research as a member of the Borland Groover Research Foundation. He completed his residency and fellowship at the University of Minnesota. He has been in private practice for 14 years.
Hoffman, J.S. and Benditt, E.P. Changes in high density lipoprotein content following endotoxin administration in the mouse. Formation of serum amyloid protein-rich subfractions. J. Biol. Chem. 257:10510, 1982.
Hoffman, J.S. and Benditt, E.P. Secretion of serum amyloid protein and assembly of serum amyloid protein-rich high density lipoproteins in primary mouse hepatocyte culture. J. Biol. Chem. 257:10518, 1982.
Benditt, E.P., Hoffman, J.S., Eriksen, N., Parmalee, D.C. and Walsh, K.A. SAA, an apoprotein of HDL: Its structure and function. Ann. NY Acad. Sci. 389:183, 1982.
Hoffman, J.S. and Benditt, E.P. Plasma clearance kinetics of the amyloid-related high density lipoprotein apoprotein, serum amyloid protein (apo SAA) in the mouse. Evidence for rapid apo SAA clearance. J. Clin. Invest. 71:926, 1983.
Hoffman, J.S., Ericsson, L.H., Eriksen, N., Walsh, K.A. and Benditt, E.P. Murine tissue amyloid protein AA. NH2-terminal sequence identity with only one serum amyloid protein (apo SAA) gene product. J. Exp. Med. 159:641,1984.
Meek, R.L. Hoffman, J.S. and Benditt, E.P. Amyloidogenesis. One serum amyloid A isotype is selectively removed from the circulation. J. Exp. Med. 163:449, 1986.
Abrecht, JH, Hoffman, JS, Kren, BT, Steer, CJ. Cyclin and Cyclin-depentent kinase/Mrna expression in models of regenerating liver and human liver disease. Am. J. of Physiol. 1993. 265: G857-64
Albrecht, JH, Hoffman, JS, Kren, BT, Steer, CJ. Changes in cell cycle-associated gene expression in a model of impaired liver regeneration. FEBS lett. 1994. 347; 157-62.